Litigation Details for Purdue Pharma LP v. Collegium Pharmaceutical Inc. (D. Del. 2015)

✉ Email this page to a colleague

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-08-06	29		quot;): U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072 (''the listed patents"). Additionally… opioid formulation, U.S. Patent No. 8,652,497 ("the '497 patent"), which is not listed…involve the '497 patent asserted in the instant litigation. The listed patents are directed to and…APl 12 that is the subject of numerous patents ('497 patent, col. 1:42-46) and is commercially available…(collectively, "Purdue"), filed this patent infringement action against Collegium Pharmaceutical	External link to document
2015-08-06	31		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,674,799; 7,674,800; 7,683,072…2015 22 October 2015 1:15-cv-00260 830 Patent None District Court, D. Delaware	External link to document
2015-10-22	39		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,674,799; 7,674,800; 7,683,072…2015 22 October 2015 1:15-cv-00260 830 Patent None District Court, D. Delaware	External link to document
2015-03-24	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,674,799; 7,674,800; 7,683,72…2015 22 October 2015 1:15-cv-00260 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document